Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
Citation: CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.

Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis

  • Received Date: 2010-06-22
  • Rev Recd Date: 2011-09-19
  • Objective To confirm the effect of gabexate mesylate on eliminating choledocholithiasis. Methods By simple randomization, the patients were assigned control group (not use gabexate), regular dosage group and high dosage group. The difference between every group on effect of eliminating choledocholithiasis by nonsurgical operation was observed. Results No significant different was found between regular dosage group and control group (P>0.05). There was a significant different between regular dosage group and high dosage group (P<0.05). Conclusion Gabexate mesylate had the effect of eliminating choledocholithiasis.
  • [1] 彭国林,李兆申. 加贝酯防治急性胰腺炎应用现状[J]. 胰腺病学,2005,5(9):177.
    [2] 陈伟成,薛 冰,李智成,等. 甲磺酸加贝酯排胆总管结石4例[J].中国临床药学杂志,2007, 16(6):385.
    [3] 倪泉兴,傅德良,虞先浚,等.加贝酯对金黄地鼠胆囊及Oddi括约肌收缩的影响[J].胰腺病学,2002,2(4):253.
    [4] 吴叔明,徐 华,戈之铮,等.加贝酯对Oddi括约肌运动的影响[J].中华消化杂志,2004,24(8):464.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2736) PDF downloads(156) Cited by()

Related
Proportional views

Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis

Abstract: Objective To confirm the effect of gabexate mesylate on eliminating choledocholithiasis. Methods By simple randomization, the patients were assigned control group (not use gabexate), regular dosage group and high dosage group. The difference between every group on effect of eliminating choledocholithiasis by nonsurgical operation was observed. Results No significant different was found between regular dosage group and control group (P>0.05). There was a significant different between regular dosage group and high dosage group (P<0.05). Conclusion Gabexate mesylate had the effect of eliminating choledocholithiasis.

CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
Citation: CHEN Wei-chen, XUE Bin, LI Zhi-chen. Clinical observation of the role of gabexate mesylate in treatment of choledocholithiasis[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(6): 449-450.
Reference (4)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return